搜索筛选:
搜索耗时4.8031秒,为你在为你在102,285,761篇论文里面共找到 12 篇相符的论文内容
发布年度:
Analysis of PDGFRA Mutations in 351 Chinese Melanomas and Evaluation of Their Sensitivity to Tyrosin
[会议论文] 作者：Jie Dai,Yan Kong,Lu Si,Zhihong Chi,Chuanliang Cui,Xinan Sheng,Jun Guo,Xiaowei Xu,Ruifeng Yang,Shujing,
来源：第十六届全国临床肿瘤学大会暨2013年CSCO学术年会 年份：2013
...
Nanosecond Pulsed Electric Fields Enhance Inhibition Effect and Reverse Resistance of Molecular Targ
[会议论文] 作者：Jie Dai,Yan Kong,Zhihong Chi,Lu Si,Xinan Sheng,Chuanliang Cui,Jun Guo,Shan Wu,Jue Zhang,Jing Fang,
来源：第十七届全国临床肿瘤学大会暨2014年CSCO学术年会 年份：2014
...
Analysis of PDGFRA Mutations in 351 Chinese Melanomas and Evaluation of Their Sensitivity to Tyrosin
[会议论文] 作者：Jie Dai,Yan Kong,Xiaowei Xu,Lu Si,Zhihong Chi,Chuanliang Cui,Xinan Sheng,Ruifeng Yang,Shujing Liu,Jun,
来源：第十六届全国临床肿瘤学大会暨2013年CSCO学术年会 年份：2013
PDGFRα is a target for tyrosine kinase inhibitors(TKIs)-based targeted therapy.Dysregulation of PDGFRα has been reported in many cancers.However, PDGFRA mutations in melanomas have not been well studi...
Nanosecond Pulsed Electric Fields Enhance Inhibition Effect and Reverse Resistance of Molecular Targ
[会议论文] 作者：Jie Dai,Shan Wu,Yan Kong,Zhihong Chi,Lu Si,Xinan Sheng,Chuanliang Cui,Jue Zhang,Jing Fang,Jun Guo,
来源：第十七届全国临床肿瘤学大会暨2014年CSCO学术年会 年份：2014
Purpose: Molecular targeting therapy is of great importance for the treatment of advanced melanoma.However, some melanoma patients invariably acquire resistance to molecular targeting agents after a p...
Predictive value of MITF gene amplification in metastatic melanoma patients receiving endostar and d
[会议论文] 作者：Chuanliang Cui,Jiafang Ma,Yan Kong,Lu Si,Zhihong Chi,Xinan Sheng,Bixia Tang,Lili Mao,Siming Li,Bin Lian,
来源：第十六届全国临床肿瘤学大会暨2013年CSCO学术年会 年份：2013
A phase Ⅱ, randomized study suggests that recombinant human endostatin(endostar)plus dacarbazine can yield a significant improvement in PFS and OS.Intratumoral Microphthalmia-associated transcription...
Restoration of microRNA-18a results in an improvement of Imatinib therapy on secondary imatinib-resi
[会议论文] 作者：Yan Kong,Long Liang,Lu Si,Lili Mao,Bixia Tang,Jie Dai,Zhihong Chi,Xinan Sheng,Chuanliang Cui,Siming Li,
来源：第十六届全国临床肿瘤学大会暨2013年CSCO学术年会 年份：2013
...
Restoration of microRNA-18a results in an improvement of Imatinib therapy on secondary imatinib-resi
[会议论文] 作者：Yan Kong,Long Liang,Xiaowei Xu,Lu Si,Lili Mao,Bixia Tang,Jie Dai,Zhihong Chi,Xinan Sheng,Chuanliang Cui,
来源：第十六届全国临床肿瘤学大会暨2013年CSCO学术年会 年份：2013
Imatinib generated remarkable clinical response in melanomas harboring c-kit mutation.However,melanoma resistance to imatinib develops rather quickly in most of the patients....
[会议论文] 作者：Yan Kong,Yiqian Li,Lu Si,Zhihong Chi,Xinan Sheng,Chuanliang Cui,Xiaowen Wu,Jie Dai,Lili Mao,Bin Lian,,
来源：第十七届全国临床肿瘤学大会暨2014年CSCO学术年会 年份：2014
...
A Randomized Phase Ⅱ Study Evaluating the Activity of Bevacizumab in Combination With Carboplatin Pl
[会议论文] 作者：Xinan Sheng,Zhihong Chi,Bixia Tang,Jun Guo,Lu Si,Bin Lian,Jie Dai,Chuanliang Cui,Xieqiao Yan,Lili Mao,
来源：第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 年份：2015
目的： Mucosal melanoma is rare in Caucasian population but account for 25％ in Asian population.It is usually associated with extremely poor prognosis.No stand...
A Randomized, Open-label, Multi-center Phase Ⅱ Study to Compare Bevacizumab plus Sorafenib Versus So
[会议论文] 作者：Zhihong Chi,Bin Lian,JieDai,Xinan Sheng,Lili Mao,Yan Kong,Chuanliang Cui,Bixia Tang,Jun Guo,Siming Li,
来源：第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 年份：2015
目的： There is no standard treatment in patients with renal cell carcinoma that was previously treated with VEGF-targeted therapies and mTOR inhibitors.From...
A Randomized, Open-label, Multi-center Phase Ⅱ Study to Compare Bevacizumab plus Sorafenib Versus So
[会议论文] 作者：Jun Guo,Xinan Sheng,Zhihong Chi,Chuanliang Cui,Lu Si,Siming Li,Lili Mao,Bin Lian,Bixia Tang,Xieqiao Yan,
来源：第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 年份：2015
目的： There is no standard treatment in patients with renal cell carcinoma that was previously treated with VEGF-targeted therapies and mTOR inhibitors.From the Gold study, Sorafenib might be an option...
A Randomized Phase Ⅱ Study Evaluating the Activity of Bevacizumab in Combination With Carboplatin Pl
[会议论文] 作者：Xinan Sheng,Lu Si,Zhihong Chi,Chuanliang Cui,Siming Li,Lili Mao,Bin Lian,Bixia Tang,Xieqiao Yan,Xuan,
来源：第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 年份：2015
目的： Mucosal melanoma is rare in Caucasian population but account for 25％ in Asian population.It is usually associated with extremely poor prognosis.No standard treatment for advanced mucosal melanoma...
相关搜索：
